| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10963065 | Vaccine | 2016 | 6 Pages |
Abstract
LAIV provided significant protection against B/Yamagata influenza but not against A/H1N1pdm09 in children aged 2-17 years in 2013-2014, resulting in a proposed change of the 2015-2016 formulation with a new and more heat-stable A/H1N1pdm09 LAIV strain.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Herve Caspard, Manjusha Gaglani, Lydia Clipper, Edward A. Belongia, Huong Q. McLean, Marie R. Griffin, H. Keipp Talbot, Katherine A. Poehling, Timothy R. Peters, Naomi Veney, Christopher S. Ambrose,